NFA
PTCT icon

Nationwide Fund Advisors’s PTC Therapeutics PTCT Stock Holding History

Nationwide Fund Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-21,718
Closed -$435K – 1591
2017
Q3 		$435K Buy
21,718
+2,713
+14% +$53.1K ﹤0.01% 2253
2017
Q2 		$348K Sell
19,005
-15,100
-44% -$203K ﹤0.01% 2363
2017
Q1 		$336K Sell
34,105
-15,200
-31% -$184K ﹤0.01% 2364
2016
Q4 		$538K Buy
49,305
+14,005
+40% +$147K ﹤0.01% 2147
2016
Q3 		$495K Hold
35,300
– – ﹤0.01% 2186
2016
Q2 		$248K Hold
35,300
– – ﹤0.01% 2508
2016
Q1 		$227K Buy
35,300
+4,464
+14% +$77.5K ﹤0.01% 2478
2015
Q4 		$999K Buy
30,836
+482
+2% +$14.2K ﹤0.01% 1736
2015
Q3 		$810K Sell
30,354
-18,260
-38% -$781K ﹤0.01% 1834
2015
Q2 		$2.34M Sell
48,614
-7,945
-14% -$464K 0.01% 1348
2015
Q1 		$3.44M Sell
56,559
-1,610
-3% -$98.2K 0.01% 1167
2014
Q4 		$3.01M Buy
58,169
+28,539
+96% +$1.26M 0.01% 1204
2014
Q3 		$1.3M Buy
29,630
+12,609
+74% +$394K 0.01% 1697
2014
Q2 		$445K Buy
17,021
+8,307
+95% +$178K ﹤0.01% 2326
2014
Q1 		$228K Buy
8,714
+1,316
+18% +$35.4K ﹤0.01% 2436
2013
Q4 		$126K Buy
7,398
+4,598
+164% +$80.8K ﹤0.01% 2885
2013
Q3 		$60K Buy
+2,800
New +$48.7K ﹤0.01% 3032

Other funds holding PTCT

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Nationwide Fund Advisors's PTCT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of PTC Therapeutics (PTCT) in Q4 2017, closing a stake of 21,718 shares — an estimated $435K sold.

Nationwide Fund Advisors first reported a position in PTCT in Q3 2013 and held it in 17 quarters. The position peaked at $3.44M in Q1 2015. 125 funds tracked by Wall St. Rank hold PTCT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining PTC Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 21,718 PTC Therapeutics shares in Q4 2017, an estimated $435K.
  • Nationwide Fund Advisors first reported a position in PTC Therapeutics in Q3 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's PTC Therapeutics position peaked at $3.44M in Q1 2015.
  • 125 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.